The Akt/Mcl-1 pathway plays a prominent role in mediating pro-survival signals derived from the B-cell receptor in chronic lymphocytic leukemia B-cells

被引：1
|
作者：
Longo, Pablo G. [1 ]
Laurenti, Luca [2 ]
Gobessi, Stefania [1 ]
Sica, Simona [2 ]
Leone, Giuseppe [2 ]
Efremov, Dimitar G.
机构：
[1] ICGEB, Mol Hematol Grp, Rome, Italy
[2] Catholic Univ Hosp A Gemelli, Dept Hematol, Rome, Italy
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.341.341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
341
引用
收藏
页码：107A / 107A
页数：1
相关论文
共 50 条
  • [31] Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals
    McCaig, Alison M.
    Cosimo, Emilio
    Leach, Michael T.
    Michie, Alison M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (02) : 199 - 211
  • [32] ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation
    Russo, Maria
    Spagnuolo, Carmela
    Volpe, Silvestro
    Tedesco, Idolo
    Bilotto, Stefania
    Russo, Gian Luigi
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (07) : 927 - 936
  • [33] BAFF support survival of chronic lymphocytic leukemia B cells by a pathway independent of stromal derived factor-1α.
    Nishio, M
    Tsukada, N
    Kitada, S
    Ohata, J
    Zvaifler, NJ
    Reed, JC
    Kipps, TJ
    BLOOD, 2004, 104 (11) : 528A - 528A
  • [34] Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis
    Edelmann, Jennifer
    Dokal, Arran
    Holzmann, Karlheinz
    Britton, David James
    Vilventhraraja, Emma
    Smith, Ryan Jack
    Cragg, Mark S.
    Braun, Andrejs
    Doehner, Hartmut
    Cutillas, Pedro
    Gribben, John G.
    BLOOD, 2019, 134
  • [35] The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease
    Longo, P. G.
    Laurenti, L.
    Gobessi, S.
    Petlickovski, A.
    Pelosi, M.
    Chiusolo, P.
    Sica, S.
    Leone, G.
    Efremov, D. G.
    LEUKEMIA, 2007, 21 (01) : 110 - 120
  • [36] The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease
    P G Longo
    L Laurenti
    S Gobessi
    A Petlickovski
    M Pelosi
    P Chiusolo
    S Sica
    G Leone
    D G Efremov
    Leukemia, 2007, 21 : 110 - 120
  • [37] BLOCKING ENDOTHELIN-1 SIGNALING DISRUPTS LEUKEMIC CELL HOMING AND B-CELL RECEPTOR PATHWAY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Maffei, R.
    Fiorcari, S.
    Martinelli, S.
    Benatti, S.
    Rossi, D.
    Zucchini, P.
    Gaidano, G.
    Potenza, L.
    Luppi, M.
    Marasca, R.
    HAEMATOLOGICA, 2016, 101 : 48 - 49
  • [38] The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression
    A D Baudot
    P Y Jeandel
    X Mouska
    U Maurer
    S Tartare-Deckert
    S D Raynaud
    J P Cassuto
    M Ticchioni
    M Deckert
    Oncogene, 2009, 28 : 3261 - 3273
  • [39] Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood
    Bhattacharya, N.
    Diener, S.
    Idler, I. S.
    Barth, T. F.
    Rauen, J.
    Habermann, A.
    Zenz, T.
    Moeller, P.
    Doehner, H.
    Stilgenbauer, S.
    Mertens, D.
    LEUKEMIA, 2011, 25 (04) : 722 - 726
  • [40] Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood
    N Bhattacharya
    S Diener
    I S Idler
    T F Barth
    J Rauen
    A Habermann
    T Zenz
    P Möller
    H Döhner
    S Stilgenbauer
    D Mertens
    Leukemia, 2011, 25 : 722 - 726
12345